Physician profile
Norman E Waldrop
NPI 1184755621
$3,557,554.08
in general payments reported to CMS, 2019-2025
22 companies · $814K in 2025
The $814K reported for 2025 was more than what 99% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234K · 2020: $257K · 2021: $406K · 2022: $438K · 2023: $489K · 2024: $921K · 2025: $814K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.1M · Consulting Fee: $62K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $57K · Travel and Lodging: $14K · Grant: $5,000 · Food and Beverage: $3,987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,081,501.50 |
| Consulting Fee | $61,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,368.75 |
| Travel and Lodging | $14,022.95 |
| Grant | $5,000.00 |
| Food and Beverage | $3,987.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,323,704.48 | 2019-2025 | Arthrex, Distal Extremities Instruments Foot & Ankle Mis Disposables |
| Depuy Synthes Sales INC. | $123,995.05 | 2022-2025 | Motoband, Na, Minibunion |
| Crossroads Extremity Systems, LLC | $73,130.83 | 2019-2021 | |
| Linvatec Corporation | $18,379.16 | 2023-2025 | Colink Plating System, Colink Neofuse, Colink 2 |
| In2bones USA, LLC | $10,094.61 | 2021-2022 | |
| Prime Surgical, LLC | $5,549.08 | 2019-2025 | |
| Stryker Corporation | $944.84 | 2019-2025 | Asnis, Infinity Adaptis, Prostep |
| Zimmer Biomet Holdings, INC. | $574.93 | 2019-2022 | |
| Orthalign INC | $184.63 | 2025 | Orthalign Plus |
| Tybr Health, INC. | $148.15 | 2025 | B3 Gel System |
| Paragon 28, INC. | $139.44 | 2023 | Grappler |
| Bone Support INC. | $120.28 | 2020 | |
| Pylant Medical | $120.22 | 2019 | |
| Restor3d, INC. | $119.19 | 2023 | |
| Arthrosurface Incorporated | $107.43 | 2024 | Wristmotion Wrist Hemiarthroplasty System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $82.13 | 2021-2025 | Renasys Go V2 Home |
| Convatec INC. | $64.52 | 2022-2025 | |
| Conmed Corporation | $22.75 | 2025 | Visiclear, System 2450 |
| Daiichi Sankyo INC. | $19.70 | 2019 | |
| Bioventus LLC | $18.53 | 2024 | Exogen Ultrasound Bone Healing System |
| Sanofi-Aventis U.S. LLC | $17.10 | 2019 | |
| Heron Therapeutics, INC. | $17.03 | 2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Waldrop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.